Financhill
Back

Catalyst Pharmaceuticals Vs. Cytokinetics Industry Stock Comparison

Sell
39

CPRX
Catalyst Pharmaceuticals

Last Price:
15.06
Seasonality Move:
29.69%
Buy
55

CYTK
Cytokinetics

Last Price:
53.96
Seasonality Move:
7.55%
Sell
39
Catalyst Pharmaceuticals (CPRX) is a Sell

Is Catalyst Pharmaceuticals a Buy, Sell or Hold?

  • The current Catalyst Pharmaceuticals [CPRX] share price is $15.06. The Score for CPRX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • CPRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CPRX Stock Price Chart

What is Catalyst Pharmaceuticals's stock price today?

  • The Catalyst Pharmaceuticals share price today is $15.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CPRX is experiencing slight selling pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $53.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

CPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 38.69 Sell
Chaikin Money Flow: -221099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.61 - 16.49) Sell
Bollinger Bands (100): (14.38 - 16.32) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.04 Sell
Relative Strength Index (14 RSI): 46.58 Sell
Chaikin Money Flow: 781761 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.51 - 58.99) Sell
Bollinger Bands (100): (57.71 - 76.51) Sell

CPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.59 Sell
20-day SMA: 15.97 Sell
50-day SMA: 15.64 Sell
200-day SMA: 14.52 Buy
8-day EMA: 15.52 Sell
20-day EMA: 15.74 Sell
50-day EMA: 15.69 Sell
200-day EMA: 14.94 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.47 Buy
20-day SMA: 52.83 Buy
50-day SMA: 60.85 Sell
200-day SMA: 55.3 Sell
8-day EMA: 53.07 Buy
20-day EMA: 54.08 Sell
50-day EMA: 58.8 Sell
200-day EMA: 57.11 Sell

Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.

Catalyst Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):